TMRW Life Sciences vs IBM

Side-by-side comparison of AI visibility scores, market position, and capabilities

IBM leads in AI visibility (80 vs 32)

TMRW Life Sciences

EmergingHealthcare

IVF Technology Platform

TMRW Life Sciences builds AI-powered storage and tracking technology for IVF clinics that ensures embryo identity through automated monitoring and chain-of-custody verification.

AI VisibilityBeta
Overall Score
D32
Category Rank
#1 of 1
AI Consensus
63%
Trend
up
Per Platform
ChatGPT
38
Perplexity
43
Gemini
36

About

TMRW Life Sciences is a medical technology company founded in 2018 that has raised $75M to build automated storage and tracking systems for fertility clinics that protect the identity and safety of eggs and embryos during IVF treatment. The company's core product is an intelligent storage system that uses barcoded vitrification devices, automated ID verification at every handling step, and continuous environmental monitoring to ensure that embryos are stored at optimal conditions and that identity errors — which can have devastating consequences — are eliminated. TMRW uses machine learning to analyze embryo images and storage conditions, providing fertility clinics with quality control data that was previously impossible to collect at this scale. The company has deployed systems at leading fertility clinic networks across the United States and internationally. TMRW addresses a critical patient safety need as IVF volumes have grown dramatically and clinics have struggled to maintain chain-of-custody integrity with manual processes. The platform also provides operational efficiency benefits for clinic staff and generates data that can be used to improve embryo culture protocols and predict embryo viability.

Full profile

IBM

LeaderEnterprise Software

General

Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.

AI VisibilityBeta
Overall Score
A80
Category Rank
#56 of 1158
AI Consensus
67%
Trend
up
Per Platform
ChatGPT
74
Perplexity
71
Gemini
84

About

International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).

Full profile

AI Visibility Head-to-Head

32
Overall Score
80
#1
Category Rank
#56
63
AI Consensus
67
up
Trend
up
38
ChatGPT
74
43
Perplexity
71
36
Gemini
84
36
Claude
74
26
Grok
81

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.